IntelVasc Inc
Andrew Ortega-Verdaguer is the CEO and Co-Founder of IntelVasc Inc and serves as the COO (Fractional) and Board Observer for NIMBLE Diagnostics as of 2023. From June 2018 to December 2022, Andrew led the Vascular Franchise for EMEA at Penumbra, Inc., overseeing a team of 12 and collaborating with specialized medical professionals to enhance patient outcomes for serious vascular conditions. Prior experiences include roles as International Strategy Manager at Terumo Aortic and Senior Global Marketing Manager at Novartis, where expertise encompassed pulmonology, endocrinology, and cardiology. Andrew's educational background includes programs at Stanford University, the University of Michigan, IMD, IESE Business School, and advanced degrees in Pharmaceutical Marketing and Molecular Biology.
This person is not in any teams
IntelVasc Inc
IntelVasc's mission is to reduce global cardiovascular mortality by enabling early detection of vascular occlusions and empowering clinicians with precise tools to enhance follow-up care. We are developing the world’s first minimally invasive vascular sensor designed to remotely monitor vascular occlusions in Peripheral Arterial Disease (PAD) patients. Our technology aims to revolutionize cardiovascular care by anticipating vascular events, shifting from reactive to proactive management of high-risk patients.